We are live on ! Find out more
PS

Peter Svennilson Portfolio holdings

AUM $1.23B
1-Year Est. Return 301.34%
This Fund
S&P 500
This Quarter Est. Return
-25.04%
1 Year Est. Return
+301.34%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$790M
AUM Growth
-$47.5M
Cap. Flow
+$237M
Cap. Flow %
30.01%
Top 10 Hldgs %
100%
Holding
6
New
1
Increased
2
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
RVMD icon
Revolution Medicines
RVMD
+$221M
2
NGM
NGM Biopharmaceuticals, Inc. Common Stock
NGM
+$14.7M
3
CNST
Constellation Pharmaceuticals, Inc.
CNST
+$1.45M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
NGM
1
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$214M 27.04%
17,323,144
+902,315
+5% +$14.7M
CNST
2
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$190M 24.08%
6,051,376
+41,674
+0.7% +$1.45M
RVMD icon
3
Revolution Medicines
RVMD
$39.9B
$175M 22.13%
+7,977,384
New +$221M
RAPT
4
DELISTED
RAPT Therapeutics
RAPT
$144M 18.25%
847,144
– –
RCUS icon
5
Arcus Biosciences
RCUS
$3.55B
$49.1M 6.22%
3,540,850
– –
GRTS
6
DELISTED
Gritstone bio, Inc. Common Stock
GRTS
$18.1M 2.29%
3,102,934
– –

Similar funds

CT
CGM Trust Boston, Massachusetts $957M AUM
CAW
Cornerstone Advisors (Washington) Bellevue, Washington $936M AUM 8.77% 1-Year Est. Return
VIM
Veritas Investment Management London, United Kingdom $1.65B AUM 25.54% 1-Year Est. Return
SFSG
Stearns Financial Services Group Greensboro, North Carolina $639M AUM 11.66% 1-Year Est. Return
KFA
Kays Financial Advisory Atlanta, Georgia $624M AUM 9.93% 1-Year Est. Return
11A
10-15 Associates Goshen, New York $516M AUM 7.62% 1-Year Est. Return
TI
TT International London, United Kingdom $1.94B AUM
IA
Independence Advisors Wayne, Pennsylvania $466M AUM 11.32% 1-Year Est. Return

Peter Svennilson's Q1 2020 Portfolio in Review

As of Q1 2020, Peter Svennilson held 6 positions worth $790M, down 5.7% from $837M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Peter Svennilson deployed $237M of net new capital in Q1 2020, opening 1 new position and adding to 2 existing holdings. Its largest new stake was Revolution Medicines: 7,977,384 shares worth $175M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Peter Svennilson's largest Q1 2020 buy was Revolution Medicines: 7,977,384 shares worth $175M.
  • Peter Svennilson added most to NGM Biopharmaceuticals, Inc. Common Stock in Q1 2020, an estimated $14.7M increase.
  • Peter Svennilson's ten largest holdings make up 100% of its $790M portfolio in Q1 2020.
  • Peter Svennilson opened 1 new position and closed 0 in Q1 2020.
  • Peter Svennilson's portfolio value fell 5.7% quarter-over-quarter to $790M.

Based on Peter Svennilson's 13F filing for Q1 2020, filed 7 May 2020.